Introduction: Adenocarcinoma is the most common histologic type of lung cancer. To
address advances in oncology, molecular biology, pathology, radiology, and surgery of lung …

The scientific community is increasingly concerned with the proportion of published
“discoveries” that are not replicated in subsequent studies. The field of rodent behavioral …

Background Current clinical therapy of non-small cell lung cancer depends on histo-
pathological classification. This approach poorly predicts clinical outcome for individual …

Purpose Recent findings that human serum contains stably expressed microRNA (miRNA)
have revealed a great potential of serum miRNA signature as disease fingerprints to predict …

Although prognostic gene expression signatures for survival in early-stage lung cancer have
been proposed, for clinical application, it is critical to establish their performance across …

Paralleling the diversity of genetic and protein activities, pathologic human tissues also
exhibit diverse radiographic features. Here we show that dynamic imaging traits in non …

Articles may be retracted when their findings are no longer considered trustworthy due to
scientific misconduct or error, they plagiarize previously published work, or they are found to …

OBJECTIVE: Increasing neutrophil/lymphocyte ratios on preoperative blood tests have been
associated with worse survival after resection of colorectal cancer. We sought to determine …

We investigated whether microRNA expression profiles can predict clinical outcome of
NSCLC patients. Using real-time RT-PCR, we obtained microRNA expressions in 112 …

Purpose The JBR. 10 trial demonstrated benefit from adjuvant cisplatin/vinorelbine (ACT) in
early-stage non–small-cell lung cancer (NSCLC). We hypothesized that expression profiling …